Why UnitedHealth Group is going all in on Amedisys

The latest stories trending on MedCity News.

Editor's Pick

Top Story Why UnitedHealth Group Is Going All in on Amedisys UnitedHealth Group's Optum is acquiring Amedisys through an all-cash transaction for $101 per share, the companies announced Monday. The move represents a continuing shift to home-based care, several experts said. Sponsored Content TriNet Pharma Highlights the Rise of the Medical Science Liaison and Honors Legacy of Its Founder Presented by MedCity News & TriNet Pharma As pharmaceutical reps are used less and less, the role of the MSL has become more prominent as a conduit between life sciences companies and external stakeholders for drug development. Learn More>>

Featured News

A Startup Wins the First FDA Approval of a Cell Therapy for Type 1 Diabetes CellTrans's Lantidra is now the first FDA-approved cell therapy for type 1 diabetes. The therapy is made from islet cells sourced from deceased donors. Medical Expenses Will Rise by 7% Next Year, Report Predicts New research predicts that healthcare costs will increase by 7% next year. The estimate is higher than the projected medical cost trends in 2022 and 2023 — which were 5.5% and 6.0%, respectively. Quantum Health Teams Up with Progyny for Family Building Benefits Offering Progyny is now a "preferred partner" on Quantum's Comprehensive Care Solutions platform, which is a group of benefits solutions that Quantum's more than 500 employer clients can choose to work with. Hospitals and Health Systems Realize Growth Advantage of a Specialty Pharmacy Partnership Implementing a specialty pharmacy strategy and approach for growth not only creates a revenue stream for the system, but also establishes a high-touch patient engagement program that becomes a differentiator in the way service is delivered for their community.

Resources

MedCity Moves Podcast: Recent Hires, Layoffs & an Interview with Danny Sanchez, CEO of EmpiRx Health Presented by MedCity News In this month's episode, we dive into some of the recent executive appointments occurring in the healthcare sector, as well as layoffs affecting the industry. We also hear from Danny Sanchez, who recently became the new CEO of EmpiRx Health, a value-based pharmacy benefit manager. Listen Now

MedCity News • PO Box 901 • New York, NY unsubscribe